Clinical Trial

XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer

Name: XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer — clinical trial record (NCT07114666)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This is a single-center, open label, single-arm, investigator-initiated study to evaluate the efficacy and safety of XH001 (neoantigen cancer vaccine) in combination with chemotherapy as Adjuvant Therapy in pancreatic cancer patients following surgical resection.

Trial Details

NCT Number	NCT07114666
Lead Sponsor	Peking Union Medical College Hospital
Conditions	Pancreatic Cancer
Enrollment	12 participants
Start Date	2025-08-18
Primary Completion	2029-08 (estimated)
Study Completion	2030-08 (estimated)
Updated on ClinicalTrials.gov	2025-08-11